©2024 Stanford Medicine
Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy
Recruiting
I'm InterestedTrial ID: NCT05153629
Purpose
The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a
pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The
primary aim for the investigators is to determine if use of a TENS unit will reduce
post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to
assess if it can help minimize narcotic use.
Official Title
Noninvasive Electrical Stimulator as an Adjunct for Pain Control After Ureteroscopic Stone Management
Stanford Investigator(s)
Simon Conti
Clinical Associate Professor, Urology
Eligibility
Inclusion Criteria:
- Adult patients undergoing standard of care ureteroscopy and laser lithotripsy for
urinary stone disease
- Patients receiving a stent following their ureteroscopy and laser lithotripsy
Exclusion Criteria:
- Children
- Pregnant patients
- Patients unable to answer pain questionnaire
- Patients undergoing PCNL
- Patients being treated for Urologic malignancy with ureteroscopy
- Patients who require long term or chronic ureteral stent management
- Patient with implantable stimulators
- Patient with epilepsy
- Patients undergoing laser lithotripsy without stent placement
Intervention(s):
device: TENS
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Simon Conti, MD
650-723-3391